M-tron Industries heads into its third-quarter report with an unusual disconnect. Its order book has never looked healthier, yet its shares have rarely looked worse. Backlog climbed to a record $84 million last quarter, up 37% from a year earlier, and management said more than half of next year's production is already spoken for. The stock has fallen about 32% since that report, trailing the S&P 500 by roughly 26 percentage points. The report due before the open on November 12 has to show whether the margin and dilution pressures behind that selloff are stabilizing or still getting worse.

The Street expects earnings of $0.51 a share on revenue of $15.4 million. That implies sales growth of nearly 9% from a year ago but a 19% drop in EPS from $0.63. The revenue figure is only a modest step up from last quarter's $15.1 million. It also marks a slowdown from the 13.8% growth posted in the second quarter. That cautious pace fits what management described: backlog now exceeds what the company can produce in the near term. With demand plentiful, this quarter's top line is really a measure of factory output. Any sign that throughput is improving, or that revenue is beginning to catch up with bookings, would matter more than the headline beat or miss.

Gross margin is the number most likely to move the stock. Margin slid to 41.2% last quarter, down from 44.9% in the first quarter and 46.9% in the fourth quarter of fiscal 2025. Management attributed part of the decline to a roughly half-million-dollar stock compensation charge tied to accelerated bonus vesting. The rest came from the cost of ramping new programs. For the second half, management guided to a margin of about 41.5% to 43.5%. That is a lower band than the company enjoyed a year ago. A print near the midpoint would suggest last quarter was the trough, especially once the one-time charge falls away. A reading at or below the bottom of the range would raise questions about whether ramp costs are a lasting feature of this growth phase rather than a passing toll. Tariffs, which cost about 1.1 points of margin last quarter, remain a smaller but persistent drag.

The EPS comparison carries its own noise. The April rights offering raised $42.1 million and expanded the share count, so per-share earnings will struggle against last year regardless of operating performance. Adjusted EBITDA, which rose 42% last quarter, is a cleaner gauge of whether the business is generating operating leverage. On the demand side, the new catalysts deserve updates. These include counter-drone and electronic warfare orders for phased-array radar oscillators, about $12 million in bookings for products that sold only around $200,000 last year, and the Skyline Instruments investment in GPS-denied timing. Book-to-bill has run above 1.0 for three straight quarters, and a fourth would reinforce the demand story. Progress on deploying the rights-offering cash toward an acquisition, which management targeted for this year, is another item to check.

Sentiment has soured sharply. Readings have moved from essentially neutral before the last report to firmly bearish now. The stock trades at $57.30, just above its post-earnings low of $57.15 and well beneath its 200-day moving average near $75. The entire trading range has shifted lower from the prior quarter's $72 to $105 band. That washed-out positioning lowers the bar somewhat, though it guarantees nothing.

The core question is straightforward. M-tron has proven it can win orders. This quarter needs to show that it can convert a swelling backlog into revenue without surrendering more margin. If gross margin holds inside guidance and output inches higher, the selloff may look overdone. If margins slip again, investors may conclude that the growth is real but less profitable than they had hoped.